Skip to content

Johan Ræder

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

2 papers in the library · 1 citation · publishing 2024-2025

Papers

Effects of ketamine and propofol on muscarinic plateau potentials in rat neocortical pyramidal cells.

PloS one January 1, 2025 Anne S Fleiner, Daniel Kolnier, Nicholas Hagger-Vaughan et al. 1 citation

Propofol and ketamine, two common general anesthetics, affect consciousness differently—propofol produces a deeply unconscious state with few dreams, while ketamine often leads to vivid dreaming. In rat brain slices of the medial prefrontal cortex, an area linked to conscious access and working memory, researchers added muscarine to mimic an aroused state and recorded electrical activity in layer 2/3 pyramidal cells. Muscarine triggered long-lasting depolarizing plateau potentials and spiking. Pre-incubation with a low dose of propofol reduced these plateau potentials and significantly reduced spiking, whereas a low dose of ketamine appeared to enhance them, though not significantly. A high dose of ketamine suppressed both. The contrasting effects on plateau potentials may relate to the different clinical experiences of dreaming under these drugs.

Effects of ketamine and propofol on muscarinic plateau potentials in rat neocortical pyramidal cells

bioRxiv Preprint Server February 14, 2024 Anne S. Fleiner, Daniel Kolnier, Nicholas Hagger-Vaughan et al. preprint

Propofol and ketamine are both general anaesthetics but produce markedly different states of consciousness. Propofol induces a deeply unconscious state with few or no dream reports, whereas ketamine anaesthesia is frequently followed by reports of vivid dreams. The abstract contrasts these two drugs' effects on awareness and dreaming, highlighting that different anaesthetics can produce distinct subjective experiences even when both cause loss of consciousness.